KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Globus Medical (GMED) Revenue (2016 - 2025)

Globus Medical's Revenue history spans 15 years, with the latest figure at $826.4 million for Q4 2025.

  • For Q4 2025, Revenue rose 25.73% year-over-year to $826.4 million; the TTM value through Dec 2025 reached $2.9 billion, up 16.65%, while the annual FY2025 figure was $2.9 billion, 16.65% up from the prior year.
  • Revenue reached $826.4 million in Q4 2025 per GMED's latest filing, up from $769.0 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $826.4 million in Q4 2025 to a low of $227.3 million in Q1 2021.
  • Average Revenue over 5 years is $450.4 million, with a median of $337.6 million recorded in 2023.
  • Peak YoY movement for Revenue: skyrocketed 124.6% in 2023, then fell 1.41% in 2025.
  • A 5-year view of Revenue shows it stood at $250.0 million in 2021, then grew by 9.79% to $274.5 million in 2022, then skyrocketed by 124.6% to $616.5 million in 2023, then rose by 6.61% to $657.3 million in 2024, then rose by 25.73% to $826.4 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Revenue are $826.4 million (Q4 2025), $769.0 million (Q3 2025), and $745.3 million (Q2 2025).